The search terms used were glucagon-like peptide 1 receptor agonist, exenatide, liraglutide, dulaglutide, lixisenatide, semaglutide, albiglutide, taspoglutide, loxenatide, diabetes mellitus, obesity and randomized controlled trial
( ) 14 2 1 [21]
This approach ensures sustainable weight loss, as rapid weight reduction over a short period may increase the risk of the yo-yo effect or regaining weight after discontinuing the medication
Learn more about the Affinity team Michael Koehler, MD Affinity's Medical Director Real patients , real results Started my journey on December 9, 2023
Nature Medicine 2024: s41591-024-03018-2 48-week MRI-PDFF liver fat reduction (51% at 1 mg, 86% at 12 mg)
Veel gebruikers zoeken naar dit soort ondersteuning, vooral wanneer ze moeite hebben met snacken of overeten